Dr. Sheyn discusses a new specialty clinic for female pelvic cancer survivors at UHMarch 23rd 2023
"UH is working on starting clinics throughout rural Northeast Ohio, and we're meeting to develop a FPMRS program, both virtual and in-person, so patients can have access to this point of care," says David Sheyn, MD.
MAPP study utilizes separate measures for pelvic pain and urinary symptom severityMarch 21st 2023
“As part of the [MAPP] network, and the research that it did, we recognized that it was really important to consider pelvic pain symptoms separately from urinary symptoms,” says Alisa J. Stephens-Shields, PhD.
What might future research on Roe v Wade reversal’s effects on reproductive care entail?March 19th 2023
“That's not something we're going to know potentially for many years, but I do think all of us are wondering, are we going to see much more interest in vasectomy reversals down the line?” says Sarah Vij, MD.
Dr. Sridhar on long-term follow-up from the JAVELIN Bladder 100 trialMarch 14th 2023
Regardless of the type of chemotherapy regimen received, there was a benefit with the use of frontline avelumab maintenance in patients with locally advanced or metastatic urothelial carcinoma, explains Srikala S. Sridhar, MD.
Dr. Zhang on second-line treatment and beyond in refractory metastatic renal cell carcinomaMarch 10th 2023
“One of the key challenges in the refractory renal cell population is identifying mechanisms of resistance to immune checkpoint inhibitors, and really delving in and figuring out how to target those mechanisms of resistance,” says Zhang.